Our mouse AP model was treated with a CXCR3 antagonist that blocks the activity of CXCL9,10 and 11 and we then evaluated the expression of the macrophage-derived proinflammatory cytokines involved in bone resorption. The gene discussed is CXCR3; the disease is alkaline phosphatase measurement.